Skip to content

WE-PHARMA

Active Private limited companyfounded 2009active for 17 yearsRue Sous-le-Château 51, 4500 HuyKBO/BCE: BE 0810.070.556 subsidiary of SAGAFIL#1 company by total assets in Huy, Administrative and support services sector
WE-PHARMA
Financial year 2025
Follow ReportCompare

Annual accounts 2025

abbreviated format, filed on 30-09-2026, 61 days late
€1.2m
▼ 3.8%
-€80,363
▼ €362,103
€161,530
▼ 67.2%
-€2.0m
▼ €2.2m
30.7%
▼ 6.1 percentage points
2.11
▲ 0.80
In the rankings #1 company by total assets in Huy, Administrative and support services sector#1 company by equity in Huy, Administrative and support services sector

Money flows

no detail for 2025

Balance sheet

balance sheet total €4.5m on 31-12-2025
What the company ownsHow it is paid for

in €m

in €m

Position in the sector

Compare with sector

30.7%

Higher than 41% of 2,829 companies in 2025.

2.11

Higher than 64% of 2,718 companies in 2025.

-49.5%

Lower than 95% of 2,776 companies in 2025.

WE-PHARMA Middle half of the sector 80% of the sector Abbreviated accounts in office administrative support (NACE 82)

Net result: bottom quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter · Staff: top quarter

Staff

€54,075

Staff costs divided by the average number of full-time equivalents.

+8 people

people who joined people who left

In 2025, 30 people joined and 22 left.

Staff figure correction
  • 2023 The accounts state 504,402.7 FTE. That amounts to under EUR 100 of staff costs per FTE. The figure is therefore left out.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019201820172016201520142013201220112010
Balance sheet: assets
20/58 4.5m3.5m2.1m1.7m1.3m978,581932,737923,891586,219603,133471,948445,199469,181526,157570,992583,416
20 ---------2874145426697979241,052
21/28 2.1m1.2m385,167398,518421,613344,274268,469286,044250,506275,077279,992304,546332,811369,293408,731446,125
21 921,295-----03,36216,81230,26343,71357,16370,61384,06297,513110,963
22/27 1.2m1.2m384,734398,085421,180344,274268,469282,682227,444238,565229,616240,591256,379279,434306,544331,611
22 466,668456,289214,195220,870237,290250,495260,596269,708194,204215,112227,097235,837247,526256,165267,549278,933
23 215,29493,870------10,10017,1712,2902,8883,4873,5213,5834,077
24 496,705651,747-2,3864,7704,7697,87312,97423,1406,2822291,8665,36619,74835,32847,767
26 --170,539174,829179,12089,010----------
28 433433433433433---6,2506,2506,2506,2505,1505,0003,7502,500
29/58 2.4m2.3m1.7m1.3m839,153634,307664,268637,847335,713327,768191,956140,653136,370156,864162,261137,291
3 859,714874,701470,692426,000415,610414,160420,103318,852295,325143,21669,29948,93043,87751,60951,43747,890
30/36 859,714874,701470,692426,000415,610414,160420,103318,852295,325143,21669,29948,93043,87751,60951,43747,890
40/41 1.5m1.3m882,828508,209333,189148,789217,797314,85640,206184,142122,24753,37957,55053,50857,77354,971
40 472,642692,624882,828443,857312,623145,274188,797304,82338,572181,610120,64052,87756,44351,33256,81154,964
41 1.1m628,477-64,35220,5663,51529,00010,0331,6342,5321,6075021,1072,1769627
50/53 ---------------33,303
54/58 24,73815,48985,35756,98290,35471,35826,3684,139---36,66233,73144,70151,842-
490/1 68752,873228,816271,158----1824104101,6821,2127,0461,2091,127
Balance sheet: equity and liabilities
10/49 4.5m3.5m2.1m1.7m1.3m978,581932,737923,891586,219603,133471,948445,199469,181526,157570,992583,416
10/15 1.4m1.3m141,728132,386110,64684,50362,73852,88029,06522,73221,74241,43733,09141,12432,94012,266
10/11 3.5m1.2m42,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,200
10 ---42,20042,200-----------
100 ---42,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,20042,200
13 4,2204,2204,2204,220------------
130/1 4,2204,2204,2204,220------------
130 ---4,220------------
1311 4,2204,2204,220-------------
14 -2.1m99,54395,30885,96668,44642,30320,53810,680-13,135-19,468-20,458-763-9,109-1,076-9,260-29,934
17/49 3.1m2.2m1.9m1.5m1.2m894,078869,999871,011557,154580,401450,206403,762436,090485,033538,052571,150
17 2.0m458,5451.3m960,906595,238638,019395,757436,454251,326272,284292,816312,180347,221381,956415,258443,186
170/4 2.0m458,5451.3m960,906595,238338,019195,757236,454251,326272,284292,816312,180347,221381,956415,258443,186
178/9 -----300,000200,000200,000--------
42/48 1.1m1.7m625,669567,575554,882256,059474,242434,557305,828308,117157,39091,58288,869103,077122,794127,964
42 130,895140,73675,442107,84558,25750,51133,30546,44946,10648,01644,04735,04136,41833,30231,82229,994
43 775,0001.0m------41,21055,42732,797-----
430/8 775,0001.0m------41,21055,42732,797-----
44 175,13372,263182,690163,298104,1232,40398,552177,59629,77743,20865,87145,94845,86955,92571,95169,284
440/4 175,13372,263182,690163,298104,1232,40398,552177,59629,77743,20865,87145,94845,86955,92571,95169,284
45 61,722125,09112,97516,87012,97510,2316,70522,12519,42715,10814,2643,500-4,9042,276243
450/3 -40,7258,62511,8902,7754,846--9013,9672,8183,500-3,050422243
454/9 61,72284,3664,3504,98010,2005,3856,70522,12518,52611,14111,446--1,8541,854-
47/48 -367,686354,561279,562379,527192,914335,680188,387169,308146,3584127,0936,5828,94616,74528,444
492/3 -1,218--------------
Income statement
70 -2.3m--------------
76A -528,881--------------
9900 1.2m1.3m567,247525,179255,639299,109190,158221,013142,446130,86957,31661,89257,77375,57386,89789,272
60/61 -1.8m--------------
62 1.1m769,515504,403462,412189,584239,253148,648169,22179,47077,08930,405-----
630 241,893210,13423,09523,09523,09523,09517,60617,60624,81731,77627,50430,29641,98741,47142,36077,000
631/4 111---------------
640/8 7,91516,2343,5783,4795,0092,1989881,0691,9181,8862,0171,9304,1162,1031,6501,994
66A ------------70---
9901 -80,363281,74036,17236,19337,95134,56322,91633,11736,24120,118-2,61029,66611,67031,99942,88710,278
75/76B 2500--------41987279461
75 2500--------41987279461
65/66B 2.2m233,30526,83014,45311,80812,79813,0589,30229,90918,05317,08917,82119,66520,82522,29240,672
65 237,400233,30526,83014,45311,80812,79813,0589,30229,90918,05317,08917,82119,66520,82522,29240,672
66B 1.9m---------------
9903 -2.2m48,4359,34221,74026,14321,7659,85823,8156,3322,064-19,69511,846-7,96711,24620,674-29,934
67/77 -44,200-------1,074-3,500663,062--
9904 -2.2m4,2359,34221,74026,14321,7659,85823,8156,332990-19,6958,346-8,0338,18420,674-29,934
9905 -2.2m4,2359,34221,74026,14321,7659,85823,8156,332990-19,6958,346-8,0338,18420,674-29,934
Appropriation of the result
9906 -2.1m99,54395,30890,18668,44642,30320,53810,680-13,135-19,468-20,458-763-9,109-1,076-9,260-29,934
14P 99,54395,30885,96668,44642,303-----------
691/2 ---4,220------------
6920 ---4,220------------
694/7 0---------------
697 0---------------
Social balance sheet
9087 19.614.9------32.7------
Hours worked1013 32,05725,821------5,265-------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 20 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 30-09-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 61 days after the deadline. Filed on 30 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00534308.

Financial year Type Filed Reference Document
31-12-2025 abbreviated format 30-09-2026 2026-00534308 PDF
31-12-2024 full format 07-07-2025 2025-00244602 PDF
31-12-2023 full format 30-08-2024 2024-00430148 PDF
31-12-2022 micro format 31-07-2023 2023-00308754 PDF
31-12-2021 micro format 20-09-2022 2022-20435710 PDF
31-12-2020 full format 23-11-2021 2021-78100209 PDF
31-12-2019 full format 14-10-2020 2020-61800246 PDF
31-12-2018 full format 18-07-2019 2019-35300100 PDF
31-12-2017 full format 08-10-2018 2018-69200061 PDF
31-12-2016 full format 31-08-2017 2017-59900182 PDF
31-12-2015 full format 14-12-2016 2016-70000378 PDF
31-12-2014 full format 26-05-2015 2015-13200300 PDF
31-12-2013 full format 11-06-2014 2014-16800374 PDF
31-12-2012 full format 30-05-2013 2013-14300275 PDF
31-12-2011 full format 30-08-2012 2012-50700220 PDF
31-12-2010 full format 18-05-2011 2011-11600145 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019201820172016201520142013201220112010
161,530491,87459,26759,28861,04657,65840,52250,72361,05851,89424,89359,96253,65773,47085,24787,278
-2.0m214,36832,43744,83549,23844,86027,46441,42131,14932,7667,80838,64233,95449,65563,03447,066
1.1m1.0m9,7440100,43498,9003172,844126,8613,0782,1805,5052,0344,966521,850
9,249-69,86828,375-33,37218,99644,99022,229----2,931-10,970-7,141--
1.3m533,3871.0m694,774284,271378,248190,026203,29029,88519,65234,56649,07147,50153,78739,4679,327
-12.0%--------------
30.7%36.8%6.9%8.0%8.8%8.6%6.7%5.7%5.0%3.8%4.6%9.3%7.1%7.8%5.8%2.1%
2.111.312.672.221.512.481.401.471.101.061.221.541.531.521.321.07
1.360.801.911.470.760.860.510.730.130.600.781.001.041.020.900.70
2.261.7213.4811.5510.3910.5813.8716.4719.1725.5320.719.7413.1811.7916.3346.56
-161.4%0.3%6.6%16.4%23.6%25.8%15.7%45.0%21.8%4.4%-90.6%20.1%-24.3%19.9%62.8%-244.0%
-49.5%0.1%0.5%1.3%2.1%2.2%1.1%2.6%1.1%0.2%-4.2%1.9%-1.7%1.6%3.6%-5.1%
0.682.112.214.105.17-----------
-108 days--------------
-15 days--------------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-2024
Employees at the balance-sheet date3022
full-time89
part-time2213
in full-time equivalents20.416.7
19.614.9
On a permanent contract2420
Joined3017
Left2211

Source: social balance sheet in the 2024 to 2025 annual accounts

Securities and guarantees

on own assets and for others
Item20252024202320222021
-€770,000---

Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€194,187€1.0m€9,744-€100,001
Intangible fixed assets€945,763----
Financial fixed assets----€433
€241,893€210,134€23,095€23,095€23,095

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on WE-PHARMA

The operating result for 2025 is a loss of €80,363, after a profit of €281,740 in 2024. It is the lowest result since 2010.

Debt's share of the balance-sheet total rises from 63.2% to 69.3%. Equity and debt are higher.

Large changes and their cause
  • 2024 Equity +800%, Total assets +69% on 2023. Capital increase of €355,000 (Official Gazette 04-06-2024).

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure